LY-215840
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
LY-215,840 is an ergoline and lysergamide derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT 2 and 5-HT 7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.
LY-215,840 is an ergoline and lysergamide derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT 2 and 5-HT 7 receptors. It has anti-hypertensive and muscle relaxant effects in animal studies.
See also
Substituted lysergamide
References
Text derived from https://en.wikipedia.org/w/index.php?oldid=1370484677 under CC BY-SA 4.0; modifications have been made.